C above pre-industrial levels. There were numerous extreme weather events globally, such as a heavy downpour in the Persian ...

A Santa Rosa family that made national headlines seven years ago when a judge allowed their daughter to receive cannabis oil to stop seizures in school, is now, again, battling to keep her in school.

Stoke Therapeutics (STOK) experienced a notable price movement last quarter, with shares rising 92%. This significant gain aligns with a backdrop of market trends and developments within the company.

In recent days, Biogen and its partners announced the FDA approval and October launch of LEQEMBI Iqlik, a subcutaneous, at-home formulation for early Alzheimer's disease, along with new positive ...

What Happened? Shares of biotech company Biogen (NASDAQ:BIIB) fell 3% in the afternoon session after Needham analyst Ami ...

In December of 2022, Linda Zoslocki, a then-69-year-old retired high school counselor in Modesto, California, had a deep cough that wouldn’t go away. She was tired, and her legs had been swollen for ...

Durable reductions in seizures and continuing improvements in cognition and behavior through 3 years in patients who continued to receive zorevunersen in the open-label extension studies – – ...

CAMBRIDGE, Mass. and BEDFORD, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein ...

The FDA has also granted zorevunersen rare pediatric disease designation and Breakthrough Therapy Designation for the treatment of Dravet syndrome with a confirmed mutation not associated with gain-of ...